Coexistence of pulmonary tuberculosis with pulmonary sarcoidosis and skin sarcoidosis: a case report.

IF 1 Q3 MEDICINE, GENERAL & INTERNAL The Egyptian Journal of Internal Medicine Pub Date : 2023-01-01 DOI:10.1186/s43162-023-00221-4
Khalifa Abdulrahman Yusuf, Shadi Fayez Kanhosh, Abdulrahman Hasan Al-Madani
{"title":"Coexistence of pulmonary tuberculosis with pulmonary sarcoidosis and skin sarcoidosis: a case report.","authors":"Khalifa Abdulrahman Yusuf,&nbsp;Shadi Fayez Kanhosh,&nbsp;Abdulrahman Hasan Al-Madani","doi":"10.1186/s43162-023-00221-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Necrotising granulomatous diseases of the lungs exhibit a narrow range of differential diagnoses. Tuberculosis accounts for most of these cases, while sarcoidosis is an uncommon entity in this group but both possess similar clinical and radiological similarities. One must consider a diagnosis of sarcoidosis once the standard anti-mycobacterial medications fail to achieve a clinical improvement. The case described highlights the coexistence of tuberculosis and sarcoidosis which is a rare entity in the medical literature.</p><p><strong>Case presentation: </strong>A 57-year-old male presented with respiratory symptoms and was diagnosed with tuberculosis (TB) demonstrating a polymerase chain reaction (PCR) test positive showing microbial DNA in bronchial washing. The patient started standard anti-TB treatment; however, he did not respond initially. Further investigations led us to diagnose pulmonary followed by skin sarcoidosis, based on histology. After confirmation of sarcoidosis, administered corticosteroids for 6 months simultaneously along with anti-TB treatment; however, anti-TB treatment was prolonged for a total of 9 months. The patient was found clinically symptomless after the completion of treatment during subsequent follow-ups.</p><p><strong>Conclusion: </strong>The use of corticosteroids as an adjunct with standard anti-TB treatment proves beneficial effects on the recovery of patients having a coexistence of pulmonary mycobacterium tuberculosis and sarcoidosis disease conditions.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"35"},"PeriodicalIF":1.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184060/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43162-023-00221-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Necrotising granulomatous diseases of the lungs exhibit a narrow range of differential diagnoses. Tuberculosis accounts for most of these cases, while sarcoidosis is an uncommon entity in this group but both possess similar clinical and radiological similarities. One must consider a diagnosis of sarcoidosis once the standard anti-mycobacterial medications fail to achieve a clinical improvement. The case described highlights the coexistence of tuberculosis and sarcoidosis which is a rare entity in the medical literature.

Case presentation: A 57-year-old male presented with respiratory symptoms and was diagnosed with tuberculosis (TB) demonstrating a polymerase chain reaction (PCR) test positive showing microbial DNA in bronchial washing. The patient started standard anti-TB treatment; however, he did not respond initially. Further investigations led us to diagnose pulmonary followed by skin sarcoidosis, based on histology. After confirmation of sarcoidosis, administered corticosteroids for 6 months simultaneously along with anti-TB treatment; however, anti-TB treatment was prolonged for a total of 9 months. The patient was found clinically symptomless after the completion of treatment during subsequent follow-ups.

Conclusion: The use of corticosteroids as an adjunct with standard anti-TB treatment proves beneficial effects on the recovery of patients having a coexistence of pulmonary mycobacterium tuberculosis and sarcoidosis disease conditions.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肺结核合并肺结节病和皮肤结节病1例。
背景:肺坏死性肉芽肿性疾病的鉴别诊断范围很窄。结核占这些病例的大多数,而结节病是一个不常见的实体,但两者具有相似的临床和放射相似之处。一旦标准的抗分枝杆菌药物未能达到临床改善,必须考虑结节病的诊断。病例描述突出肺结核和结节病共存,这是一个罕见的实体在医学文献。病例介绍:一名57岁男性出现呼吸道症状并被诊断为结核(TB),聚合酶链反应(PCR)检测显示支气管洗涤中微生物DNA阳性。患者开始标准抗结核治疗;然而,他最初没有回应。进一步的调查使我们根据组织学诊断肺部结节病继发于皮肤结节病。确诊结节病后,在抗结核治疗的同时给予皮质类固醇6个月;然而,抗结核治疗总共延长了9个月。在随后的随访中,患者完成治疗后无临床症状。结论:糖皮质激素与标准抗结核治疗相结合,对结核分枝杆菌合并结节病患者的康复有良好的促进作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
81
审稿时长
9 weeks
期刊最新文献
Predictors of COVID-19 outcome in type 2 diabetes mellitus: a hospital-based study Platelet to lymphocyte ratio: can it be an early economical mortality predictor of AKI patients? Correlation between neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with proteinuria in different stages of chronic kidney disease Sinus arrest associated with diabetic ketoacidosis regressing to sinus rhythm after compensation of diabetic process: a case report and review of literature The multidimensional benefits of eicosapentaenoic acid: from heart health to inflammatory control
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1